| Literature DB >> 34767023 |
Yiqing Wang1,2,3, Long H Nguyen1,2,3, Raaj S Mehta1,2,3, Mingyang Song1,2,4,5, Curtis Huttenhower3,6,7, Andrew T Chan1,2,6,7,8.
Abstract
Importance: Sulfur-metabolizing bacteria that reduce dietary sulfur to hydrogen sulfide have been associated with colorectal cancer (CRC). However, there are limited studies investigating the association between diet and sulfur-metabolizing bacteria in the development of CRC. Objective: To develop a dietary score that correlates with gut sulfur-metabolizing bacteria and to examine its association with CRC risk. Design, Setting, and Participants: This prospective cohort study included data from the Health Professionals Follow-up Study (1986-2014), Nurses' Health Study (1984-2016), and Nurses' Health Study II (1991-2017). Participants were US male health professionals and female registered nurses who were free of inflammatory bowel disease and cancer at baseline, with a subsample of participants who provided stool samples from 2012 to 2014. Statistical analysis was conducted from September 1, 2020, to June 1, 2021. Exposure: A dietary pattern, assessed by a food-frequency questionnaire, that most correlated with 43 sulfur-metabolizing bacteria identified through taxonomic and functional profiling of gut metagenome data. Main Outcomes and Measures: Incident CRC.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34767023 PMCID: PMC8590167 DOI: 10.1001/jamanetworkopen.2021.34308
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. Sparse Canonical Correlation Analysis of Dietary Intake and Sulfur-Metabolizing Bacteria
Pairwise Spearman correlations between selected food groups and bacteria. Numbers in parentheses are the weights for food groups and bacteria, whose linear combination maximizes the correlation (0.375). The food group weights were used to create the sulfur microbial diet score.
aStatistically significant correlations (Benjamini-Hochberg false discovery rate <0.25).
Age-Adjusted Baseline Characteristics of the HPFS, NHS, and NHSII by Quintiles of Sulfur Microbial Diet Score
| Characteristic | Sulfur microbial diet score, No. (%) | ||||
|---|---|---|---|---|---|
| Quintile 1 (lowest) | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 (highest) | |
| Men (HPFS) | |||||
| No. | 9255 | 9415 | 9349 | 9287 | 9244 |
| Age, mean (SD), y | 57 (9.8) | 55.8 (9.7) | 54.5 (9.6) | 53.4 (9.4) | 51 (8.9) |
| Race | |||||
| White | 8279 (89.5) | 8491 (90.2) | 8417 (90.0) | 8350 (89.9) | 8380 (90.7) |
| Other | 976 (10.5) | 924 (9.8) | 932 (10.0) | 937 (10.1) | 864 (9.3) |
| BMI, mean (SD) | 24.8 (3.3) | 25.3 (3.1) | 25.5 (3.2) | 25.7 (3.3) | 26.1 (3.3) |
| Physical activity, mean (SD), MET h/wk | 28.6 (29.9) | 22.8 (25.5) | 19.7 (23.4) | 17.3 (21.3) | 15.3 (20.7) |
| Smoking status | |||||
| Never | 4869 (52.6) | 4571 (48.6) | 4095 (44.8) | 3855 (41.6) | 3372 (36.5) |
| Past | 3641 (39.3) | 3901 (41.4) | 4028 (43.1) | 3913 (42.1) | 3931 (42.5) |
| Current | 375 (4.1) | 569 (6.0) | 789 (8.4) | 1143 (12.3) | 1600 (17.3) |
| Pack-years among ever smokers, mean (SD) | 14.7 (13.7) | 15.8 (14.4) | 16.8 (14.8) | 17.9 (15.3) | 19.4 (15.7) |
| Regular aspirin use | 2687 (29.0) | 2768 (29.4) | 2742 (29.3) | 2700 (29.1) | 2714 (29.4) |
| Regular NSAID use | 761 (8.2) | 895 (9.5) | 1003 (10.7) | 1037 (11.2) | 1072 (11.6) |
| Family history of CRC | 1442 (15.6) | 1420 (15.1) | 1372 (14.7) | 1377 (14.8) | 1283 (13.9) |
| Prior endoscopy | 2726 (29.5) | 2683 (28.5) | 2460 (26.3) | 2226 (24.0) | 2104 (22.8) |
| Prior physical examination | 5712 (61.7) | 5821 (61.8) | 5674 (60.7) | 5437 (58.5) | 5176 (56.0) |
| Total calorie intake, mean (SD), kcal | 2250.7 (624.7) | 2002.5 (589) | 1896.6 (576.8) | 1843.5 (591.1) | 1947.2 (640.9) |
| Western diet pattern score, mean (SD) | −0.4 (0.8) | −0.2 (0.8) | −0.1 (0.8) | 0.1 (0.9) | 0.5 (1.0) |
| Women (NHS and NHSII) | |||||
| No. | 33 585 | 33 585 | 33 708 | 33 681 | 33 688 |
| Age, mean (SD), y | 44.3 (9.8) | 43.6 (9.5) | 43.1 (9.2) | 42.5 (8.9) | 41.6 (8.4) |
| Race | |||||
| White | 31 941 (95.1) | 32 127 (95.7) | 32 225 (95.6) | 32 225 (95.8) | 32 276 (95.8) |
| Other | 1644 (4.9) | 1458 (4.3) | 1483 (4.4) | 1456 (4.3) | 1412 (4.2) |
| BMI, mean (SD) | 24.1 (4.5) | 24.2 (4.5) | 24.4 (4.6) | 24.6 (4.9) | 25.2 (5.4) |
| Physical activity, mean (SD), MET h/wk | 26.6 (31.8) | 20.3 (24.1) | 17.8 (22.2) | 15.6 (20.9) | 13.4 (18.9) |
| Smoking status | |||||
| Never | 19 892 (59.2) | 19 578 (58.3) | 19 200 (57.0) | 18 293 (54.3) | 16 683 (49.6) |
| Past | 10 129 (30.2) | 9574 (28.5) | 8964 (26.6) | 8339 (24.8) | 7589 (22.5) |
| Current | 3502 (10.4) | 4359 (13.0) | 5507 (16.3) | 7011 (20.8) | 9371 (27.8) |
| Pack-years among ever smokers, mean (SD) | 21.8 (17.1) | 23.8 (18.3) | 24.4 (18.9) | 26.1 (19.1) | 28.0 (19.8) |
| Regular aspirin use | 11 552 (34.4) | 12 415 (37.0) | 12 996 (38.6) | 13 466 (40.0) | 13 787 (40.9) |
| Regular NSAID use | 7480 (22.3) | 7987 (23.8) | 8323 (24.7) | 8450 (25.1) | 9195 (27.3) |
| Family history of CRC | 4319 (12.9) | 4220 (12.6) | 4257 (12.6) | 4237 (12.6) | 4016 (11.9) |
| Prior endoscopy | 2330 (6.9) | 2112 (6.3) | 2025 (6.0) | 1949 (5.8) | 1762 (5.2) |
| Prior physical examination | 28 467 (84.8) | 27 899 (83.1) | 27 628 (82.0) | 27 028 (80.2) | 25 915 (76.9) |
| Total calorie intake, mean (SD), kcal | 2049.1 (527.6) | 1816.9 (497.6) | 1704.9 (504.4) | 1616.2 (510.3) | 1666.2 (555.7) |
| Western diet pattern score, mean (SD) | −0.3 (0.9) | −0.2 (0.9) | −0.1 (0.9) | 0 (0.9) | 0.5 (1.1) |
| Menopausal hormone therapy | |||||
| Premenopausal | 23 971 (71.4) | 24 112 (71.9) | 24 099 (71.4) | 24 077 (71.5) | 24 236 (72.0) |
| Never used hormones | 4910 (14.6) | 4881 (14.5) | 5142 (15.3) | 5269 (15.6) | 5294 (15.7) |
| Past hormone user | 1971 (5.9) | 1957 (5.8) | 1977 (5.9) | 1907 (5.7) | 1969 (5.8) |
| Current hormone user | 2733 (8.1) | 2635 (7.8) | 2490 (7.4) | 2428 (7.2) | 2189 (6.5) |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CRC, colorectal cancer; HPFS, Health Professionals Follow-up Study; MET, metabolic equivalent task; NHS, Nurses’ Health Study; NHSII, Nurses’ Health Study II; NSAID, nonsteroidal anti-inflammatory drug.
Not adjusted for age.
Includes American Indian/Native American, Asian, Black, Hawaiian, and multiracial.
Percentages do not add up to 100% owing to missing data (3.8%-4.0% in men and 0.1%-0.2% in women), which were categorized into a missing category.
The predefined Western dietary pattern score was derived from principal component analysis.
Hazard Ratios and 95% CIs of Incident Colorectal Cancer in the Pooled Analytic Cohort, by Quintiles of Sulfur Microbial Diet Score
| Model | Sulfur microbial diet score, HR (95% CI) | |||||||
|---|---|---|---|---|---|---|---|---|
| Quintile 1 (lowest) | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 (highest) | ||||
| Colorectal cancer | ||||||||
| Cases | 650 | 693 | 642 | 636 | 596 | NA | ||
| Person-years | 1 083 910 | 1 091 687 | 1 072 512 | 1 044 147 | 985 792 | NA | ||
| Adjusted for age | 1 [Reference] | 1.12 (1.01-1.25) | 1.14 (1.02-1.27) | 1.24 (1.11-1.39) | 1.42 (1.27-1.59) | <.001 | ||
| Multivariable adjusted | 1 [Reference] | 1.10 (0.99-1.23) | 1.10 (0.98-1.23) | 1.16 (1.04-1.31) | 1.27 (1.12-1.44) | <.001 | ||
| Proximal colon cancer | ||||||||
| Cases | 264 | 265 | 238 | 232 | 201 | NA | ||
| Adjusted for age | 1 [Reference] | 1.06 (0.89-1.26) | 1.06 (0.88-1.26) | 1.15 (0.96-1.37) | 1.24 (1.03-1.50) | .02 | ||
| Multivariable adjusted | 1 [Reference] | 1.05 (0.88-1.25) | 1.03 (0.86-1.24) | 1.10 (0.91-1.33) | 1.13 (0.93-1.39) | .19 | ||
| Distal colon and rectal cancer | ||||||||
| Cases | 297 | 319 | 305 | 298 | 281 | NA | ||
| Adjusted for age | 1 [Reference] | 1.13 (0.96-1.32) | 1.17 (1.00-1.37) | 1.25 (1.06-1.47) | 1.40 (1.19-1.66) | <.001 | ||
| Multivariable adjusted | 1 [Reference] | 1.10 (0.93-1.29) | 1.12 (0.95-1.32) | 1.16 (0.98-1.38) | 1.25 (1.05-1.50) | .02 | ||
Abbreviations: HR, hazard ratio; NA, not applicable.
Trend test was performed using median value of each diet score quintile as a continuous variable.
Models were stratified by age, questionnaire cycle, and cohort.
Models were stratified by age, questionnaire cycle, and cohort, and adjusted for the following covariates: race, body mass index, family history of colorectal cancer, physical activity, smoking status, smoking pack-years, menopausal hormone use (women only), aspirin use, nonsteroidal anti-inflammatory drug use, prior endoscopy, recent physical examination, and total calorie intake.
Figure 2. Stratified Analysis of the Association Between Sulfur Microbial Diet and Risk of Colorectal Cancer (CRC)
Multivariable-adjusted hazard ratios (HRs) and 95% CIs comparing the highest quintile vs the lowest quintile of sulfur microbial diet score were calculated using Cox proportional hazards regression models stratified by age, questionnaire cycle, and cohort and adjusted for the following covariates: race, body mass index (calculated as weight in kilograms divided by height in meters squared), family history of CRC, physical activity, smoking status, smoking pack-years, menopausal hormone use (women only), aspirin use, nonsteroidal anti-inflammatory drug use, prior endoscopy, recent physical examination, and total calorie intake. P value for interaction was estimated using the likelihood ratio test comparing the model with and without the interaction term of the sulfur microbial diet score and the respective stratification variable.